A novel deep learning system for STEMI prognostic prediction from multi-sequence cardiac magnetic resonance

Yifan Chen1, Meng Jiang1, Chao Xia2

  • 1Division of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.

Science Bulletin
|November 28, 2025
PubMed

Insights

DeepSTEMI, a deep learning system, accurately predicts major adverse cardiovascular events after myocardial infarction using cardiac MRI and clinical data. This AI tool improves risk stratification for better patient outcomes.

Area of Science:

  • Cardiology
  • Artificial Intelligence
  • Medical Imaging

Background:

  • ST-elevation myocardial infarction (STEMI) poses significant cardiovascular risks.
  • Current risk scores and imaging biomarkers have limited accuracy for predicting post-STEMI outcomes.
  • Accurate early risk stratification is crucial for personalized treatment strategies.

Purpose of the Study:

  • To develop and validate DeepSTEMI, an AI system for predicting 2-year major adverse cardiovascular events (MACE) after STEMI.
  • To integrate multi-sequence cardiac magnetic resonance (CMR) images with clinical data for enhanced risk prediction.
  • To compare DeepSTEMI's performance against existing clinical risk scores and manual imaging biomarkers.

Main Methods:

  • Developed an end-to-end deep learning system (DeepSTEMI) with U-Net for segmentation and Transformer for prediction.
  • Utilized a multicenter dataset (n=610) from the EARLY-MYO-CMR registry for development.
  • Externally validated the system in 334 patients from three independent cardiac centers.

Main Results:

  • DeepSTEMI demonstrated superior predictive performance in external validation (AUC 0.894, accuracy 94.3%).
  • The model identified high-risk patients with a 20-fold increased MACE risk.
  • SHAP analysis confirmed clinical-imaging synergy, and DeepSTEMI outperformed the Eitel score across subgroups.

Conclusions:

  • DeepSTEMI offers an automated, scalable, and interpretable solution for post-STEMI risk stratification.
  • The system advances cardiovascular risk prediction beyond current limitations.
  • DeepSTEMI shows particular benefit in women and patients imaged 4-7 days post-STEMI.